Analysis of IRF8 expression by CD68+ TAMs within metastatic ccRCC samples showed prolonged progression-free survival of patients with high expression of IRF8 (Fig. 3a). The gene discussed is CD68; the disease is nonpapillary renal cell carcinoma.